Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
CA 2348885 A1 · Owner: Asner, Debra J. · Inventors: Roniker, Barbara; Asner, Debra J.; Alexander, John C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Combinations of an ACE inhibitor, an aldosterone antagonist and a loop , diuretic are described for use in treatment of circulatory disorders. Of particular interest are therapies using captopril enalapril or lisinopril co-, administered with spironolactone. This co-therapy would be particularly useful to reduce the death rate or the number of non-fatal hospitalizations or prevent the progression of congestive heart failure in patients with cardiovascular disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 5, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 5, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 5, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.